High intratumoral macrophage content is an adverse prognostic feature in anaplastic large cell lymphoma
- 16 April 2014
- journal article
- research article
- Published by Wiley in Histopathology
- Vol. 65 (4) , 490-500
Abstract
Aims: Macrophage infiltration has been associated with prognosis in several cancers, including lymphoma, but has not been assessed systematically in anaplastic large cell lymphoma (ALCL). The aim of the study was to correlate expression of the macrophage‐associated antigens CD68 and CD163 with pre‐therapeutic parameters and outcome in a cohort of treatment‐naive ALCL patients.Methods and results: Pre‐therapeutic tumour specimens from 52 patients with ALCL were included in a tissue microarray. The intratumoral macrophage content was assessed by immunohistochemical staining for CD68 and CD163, and quantified using digital image analysis. Anaplastic lymphoma kinase (ALK)‐positive patients were significantly younger and had a favourable outcome compared with ALK‐negative ALCL patients (median age: 42 versus 59 years; P = 0.008). However, ALK expression was not a significant predictor when adjusting for age. Although classical risk factors were distributed evenly between the compared groups, high intratumoral content of CD68 and/or CD163 correlated with poor outcome, in both univariate and multivariate analyses. High intratumoral CD163 content showed the strongest adverse association with both overall and progression‐free survival in ALK‐negative patients (P < 0.001).Conclusions: A high content of intratumoral CD68‐ and/or CD163‐positive macrophages correlates with an adverse outcome in ALK‐negative ALCL.Keywords
This publication has 47 references indexed in Scilit:
- Identification of a 3-gene model as a powerful diagnostic tool for the recognition of ALK-negative anaplastic large-cell lymphomaBlood, 2012
- Pathology and biology of peripheral T-cell lymphomasHistopathology, 2011
- Gene Expression Profiling Uncovers Molecular Classifiers for the Recognition of Anaplastic Large-Cell Lymphoma Within Peripheral T-Cell NeoplasmsJournal of Clinical Oncology, 2010
- Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphomaBlood, 2010
- Gene expression analysis of peripheral T cell lymphoma, unspecified, reveals distinct profiles and new potential therapeutic targetsJournal of Clinical Investigation, 2007
- Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypesBlood, 2006
- Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic targetNature Medicine, 2005
- Differential gene expression in anaplastic lymphoma kinase–positive and anaplastic lymphoma kinase–negative anaplastic large cell lymphomasHuman Pathology, 2005
- ALK‐negative anaplastic large‐cell lymphoma demonstrates similar poor prognosis to peripheral T‐cell lymphoma, unspecifiedHistopathology, 2003
- The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cellsBlood, 1985